Home

& JOHNSON JOHNSON

CIK 200406 · last filed 2025-12-01

& JOHNSON JOHNSON is a corporate insider who has filed 12 SEC Form 4 insider transactions across 8 companies since 2010. The most recent filing shows the insider sold $127.1K of CVRX on Dec 1, 2025. Across all open-market trades the lifetime net is −$121.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.87B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.87B

Companies

8

Total Filings

12

Lifetime Open-Market Net

-$121.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CVRX 10%+ Owner 4,040,861 $4.74 $19.15M -$1.25M 3 2025-12-01
KVUE 10%+ Owner 182,329,550 $19.28 $3.52B $0 1 2023-08-25
Fusion Pharmaceuticals Inc. (FUSN) Delisted 10%+ Owner 2,945,516 $21.55 $63.48M $24.65M 1 2020-07-02
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 0 — — -$101.02M 1 2017-11-22
PTGX 10%+ Owner 2,449,183 $136.11 $333.36M $14.00M 1 2016-08-18
Neurogene Inc. (AQXP) Delisted 10%+ Owner 1,383,366 — — -$68.05M 3 2015-08-12
NERV 10%+ Owner 562,520 $4.04 $2.27M $5.85M 1 2015-03-17
TENGION INC (TNGN) Delisted 10%+ Owner 119,465 — — $4.00M 1 2010-04-14

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-01 CVRX Sell (S) −12,674 -$127.1K EDGAR
2025-11-25 CVRX Sell (S) −5,400 -$54.3K EDGAR
2025-11-10 CVRX Sell (S) −105,064 -$1.07M EDGAR
2023-08-25 KVUE Other (J) −1,533,830,450 $0 EDGAR
2020-07-02 Fusion Pharmaceuticals Inc. (FUSN) Delisted Mixed +7,341,032 $24.65M EDGAR
2017-11-22 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Sell (S) −36,734,692 -$101.02M EDGAR
2016-08-18 PTGX Mixed +4,898,366 $14.00M EDGAR
2015-08-12 Neurogene Inc. (AQXP) Delisted Sell (S) −3,029,642 -$67.89M EDGAR
2015-03-17 NERV Buy (P) +1,215,806 $5.85M EDGAR
2014-12-10 Neurogene Inc. (AQXP) Delisted Sell (S) −16,600 -$128.1K EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.